Progress in immunology has identified aberrant expression of immune check point regulators, such as programmed death-1 (PD-1) and cytotoxic T-lymphocyte associated protein 4 (CTLA-4), that can dampen host anti-tumor immune response and facilitate melanoma growth. Here, CTLA4 is linked to neoplasm.